These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 19067144)

  • 1. Neuropsychiatric disorders related to interferon and interleukins treatment.
    Myint AM; Schwarz MJ; Steinbusch HW; Leonard BE
    Metab Brain Dis; 2009 Mar; 24(1):55-68. PubMed ID: 19067144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hepatitis C, interferon a and depression: main physiopathologic hypothesis].
    Vignau J; Karila L; Costisella O; Canva V
    Encephale; 2005; 31(3):349-57. PubMed ID: 16142050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Network beyond IDO in psychiatric disorders: revisiting neurodegeneration hypothesis.
    Myint AM; Kim YK
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Jan; 48():304-13. PubMed ID: 24184687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perinatal inflammatory cytokine challenge results in distinct neurobehavioral alterations in rats: implication in psychiatric disorders of developmental origin.
    Tohmi M; Tsuda N; Watanabe Y; Kakita A; Nawa H
    Neurosci Res; 2004 Sep; 50(1):67-75. PubMed ID: 15288500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Neuropsychiatric symptoms related to interferon alpha].
    Małyszczak K; Inglot M; Pawłowski T; Czarnecki M; Rymer W; Kiejna A
    Psychiatr Pol; 2006; 40(4):787-97. PubMed ID: 17068950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipopolysaccharide-induced brain activation of the indoleamine 2,3-dioxygenase and depressive-like behavior are impaired in a mouse model of metabolic syndrome.
    Dinel AL; André C; Aubert A; Ferreira G; Layé S; Castanon N
    Psychoneuroendocrinology; 2014 Feb; 40():48-59. PubMed ID: 24485475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic and hormonal regulation of tryptophan kynurenine metabolism: implications for vascular cognitive impairment, major depressive disorder, and aging.
    Oxenkrug GF
    Ann N Y Acad Sci; 2007 Dec; 1122():35-49. PubMed ID: 18077563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The psychoneuroimmuno-pathophysiology of cytokine-induced depression in humans.
    Wichers M; Maes M
    Int J Neuropsychopharmacol; 2002 Dec; 5(4):375-88. PubMed ID: 12466036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new theory of depression based on the serotonin/kynurenine relationship and the hypothalamicpituitary- adrenal axis.
    Ramírez LA; Pérez-Padilla EA; García-Oscos F; Salgado H; Atzori M; Pineda JC
    Biomedica; 2018 Sep; 38(3):437-450. PubMed ID: 30335249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kynurenine pathway metabolism and immune activation: Peripheral measurements in psychiatric and co-morbid conditions.
    Strasser B; Becker K; Fuchs D; Gostner JM
    Neuropharmacology; 2017 Jan; 112(Pt B):286-296. PubMed ID: 26924709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Indoleamine 2,3-dioxygenase in oncology and psychiatry].
    Vonka V; Horáček J
    Cas Lek Cesk; 2015; 154(1):3-10. PubMed ID: 25994821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Alpha-interferon and mental disorders].
    Debien C; De Chouly De Lenclave MB; Foutrein P; Bailly D
    Encephale; 2001; 27(4):308-17. PubMed ID: 11686052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The immune effects of TRYCATs (tryptophan catabolites along the IDO pathway): relevance for depression - and other conditions characterized by tryptophan depletion induced by inflammation.
    Maes M; Mihaylova I; Ruyter MD; Kubera M; Bosmans E
    Neuro Endocrinol Lett; 2007 Dec; 28(6):826-31. PubMed ID: 18063923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Depressive and anxiety symptoms in the early puerperium are related to increased degradation of tryptophan into kynurenine, a phenomenon which is related to immune activation.
    Maes M; Verkerk R; Bonaccorso S; Ombelet W; Bosmans E; Scharpé S
    Life Sci; 2002 Sep; 71(16):1837-48. PubMed ID: 12175700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Indoleamine 2,3-dioxygenase-dependent neurotoxic kynurenine metabolism mediates inflammation-induced deficit in recognition memory.
    Heisler JM; O'Connor JC
    Brain Behav Immun; 2015 Nov; 50():115-124. PubMed ID: 26130057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Impact of interferon alpha immunotherapy on tryptophan metabolism in patients with chronic hepatitis C. Results of a pilot studies on ten patients].
    Vignau J; Costisella O; Canva V; Imbenotte M; Duhamel A; Lhermitte M
    Encephale; 2009 Oct; 35(5):477-83. PubMed ID: 19853722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Behavioral Deficits Are Accompanied by Immunological and Neurochemical Changes in a Mouse Model for Neuropsychiatric Lupus (NP-SLE).
    Li Y; Eskelund AR; Zhou H; Budac DP; Sánchez C; Gulinello M
    Int J Mol Sci; 2015 Jul; 16(7):15150-71. PubMed ID: 26151848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon-gamma-induced conversion of tryptophan: immunologic and neuropsychiatric aspects.
    Wirleitner B; Neurauter G; Schröcksnadel K; Frick B; Fuchs D
    Curr Med Chem; 2003 Aug; 10(16):1581-91. PubMed ID: 12871129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic Mild Stress Alters Kynurenine Pathways Changing the Glutamate Neurotransmission in Frontal Cortex of Rats.
    Martín-Hernández D; Tendilla-Beltrán H; Madrigal JLM; García-Bueno B; Leza JC; Caso JR
    Mol Neurobiol; 2019 Jan; 56(1):490-501. PubMed ID: 29725904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A link between stress and depression: shifts in the balance between the kynurenine and serotonin pathways of tryptophan metabolism and the etiology and pathophysiology of depression.
    Miura H; Ozaki N; Sawada M; Isobe K; Ohta T; Nagatsu T
    Stress; 2008 May; 11(3):198-209. PubMed ID: 18465467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.